|
chemistry
|
hematology
|
---|
GOT
|
GPT
|
γ-GPT
|
T-BIL
|
CRP
|
WBC
|
RBCx104
|
Plateletx104
|
---|
Case 1 : 6 days
|
At the beginning
|
23
|
58
|
96
|
0.7
|
1.51
|
7800
|
462
|
32.2
|
4 days after
|
16
|
27
|
66
|
0.4
|
1.89
|
7800
|
430
|
36.8
|
9 days after (3 days after resumption)
|
20
|
22
|
63
| | |
10600
|
431
|
52.8
|
22 days after, (16 days After resumption)
|
17
|
12
|
45
| |
0.19
|
8000
|
440
|
51.6
|
|
chemistry
|
hematology
|
GOT
|
GPT
|
γ-GPT
|
T-BIL
|
CRP
|
WBC
|
RBCx10
4
|
Plateletx10
4
|
Case 2:19 days
|
At the beginning
|
33
|
58
|
253
|
0.6
|
8.27
|
10200
|
367
|
29.1
|
7 days after
|
20
|
57
|
244
| |
8.71
|
18800
|
297
|
20.1
|
10 days after
|
27
|
59
|
233
| |
9.35
|
37000
|
348
|
3.8
|
2 weeks after
|
29
|
46
|
210
|
1.9
|
6.53
|
11900
|
288
|
1.9
|
18 days after
|
19
|
35
|
152
|
1.6
|
5.81
|
11200
|
258
|
4.6
|
3 weeks after
|
15
|
22
|
79
| |
8.64
|
17700
|
310
|
24.2
|
|
chemistry
|
hematology
|
GOT
|
GPT
|
γ-GPT
|
T-BIL
|
CRP
|
WBC
|
RBCx10
4
|
Plateletx10
4
|
Case 3 : 2hrs
|
At the beginning
|
22
|
25
|
28
| | |
4500
|
432
|
13.6
|
45 days after (45 days after completion)
|
19
|
20
|
25
|
0.4
|
0.24
|
4500
|
439
|
15.5
|
|
chemistry
|
hematology
|
GOT
|
GPT
|
γ-GPT
|
T-BIL
|
CRP
|
WBC
|
RBC (万)
|
Plateletx10
4
|
Case 4 : 3 days
|
At the begining
|
25
|
35
|
342
| |
1.31
|
18000
|
396
|
30.6
|
2 days after
|
34
|
36
|
286
| |
0.65
|
21900
|
381
|
26
|
5 days after (2 days after completion)
|
60
|
117
|
300
| |
1.91
|
13200
|
409
|
11.7
|
- Administration of H2 did not change physiological parameters and did not cause significant deterioration of the blood chemistry such as for liver and kidney function, although some of these patients already had severe abnormalities before the H2 treatment such as thrombocytopenia of case 2.